Zomedica Corp. (ZOMDF)
About Zomedica Corp.
ZOMEDICA CORP
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $32.0M
- Net income
- -$81.9M
- Total assets
- $127.0M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Zomedica Corp. (ZOMDF) Stock Price
- Reported a net loss of $81.9M in FY2025.
- Trading 47% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Zomedica Corp..
Write a review
Zomedica Corp.: frequently asked questions
Is Zomedica Corp. an American company?
Zomedica Corp. is a US-based company headquartered in Ann Arbor, Michigan, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Zomedica Corp. headquartered?
Zomedica Corp. is headquartered in Ann Arbor, Michigan, United States.
Is Zomedica Corp. publicly traded?
Yes — Zomedica Corp. is a publicly traded company. Its stock trades under the ticker symbol ZOMDF on the OTC.
What does Zomedica Corp. do?
Zomedica Corp. is an American Pharmaceuticals company in the Health & Beauty sector.
